Evidence map›Paper›PMID 29686665›Full record

ArticleFrontiers in immunology2018

CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells.

Ayako Kurioka, Cormac Cosgrove, Yannick Simoni, Bonnie van Wilgenburg, Alessandra Geremia, Sophia Björkander, Eva Sverremark-Ekström, Christine Thurnheer, Huldrych F Günthard, Nina Khanna and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 124 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Innate Immune Protection Against HIV in the Female Genital Tract.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Differential impact of TIM-3 ligands on NK cell function.Journal for immunotherapy of cancer · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 5 countries.

Ayako KuriokaThe Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Cormac CosgroveRagon Institute of Massachusetts General Hospital, Harvard University, Massachusetts Institute of Technology, Cambridge, MA, United States.
Yannick SimoniAgency for Science, Technology and Research (ASTAR), Singapore Immunology Network (SIgN), Singapore, Singapore.
Bonnie van WilgenburgThe Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Alessandra GeremiaTranslational Gastroenterology Unit, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Sophia BjörkanderDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Eva Sverremark-EkströmDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Christine ThurnheerDivision of Infectious Diseases, University Hospital Berne, University of Berne, Berne, Switzerland.
Huldrych F GünthardDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Nina KhannaDivision of Infectious Diseases, University Hospital Basel, Basel, Switzerland.
Swiss HIV Cohort Study
Oxford IBD Cohort Investigators
Lucy Jane WalkerInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Carolina V Arancibia-CárcamoTranslational Gastroenterology Unit, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Evan W NewellAgency for Science, Technology and Research (ASTAR), Singapore Immunology Network (SIgN), Singapore, Singapore.
Christian B WillbergThe Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Paul KlenermanThe Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
University of Oxford · GBJohn Radcliffe Hospital · GBAgency for Science, Technology and Research · SGStockholm University · SENewcastle University · GBRagon Institute of MGH, MIT and Harvard · USSingapore Immunology Network · SGUniversity Hospital of Basel · CHUniversity of Bern · CHUniversity of Zurich · CH

Funding

Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG, GEORG Michael LAUER · 2009 to 2026
$48.1M
Department of Health NIHR-RP-R3-12-026Medical Research Council MC_UU_00008/7Medical Research Council MC_UU_12010/7NIAID NIH HHS U19 AI082630Wellcome Trust 109965/Z/15/ZWellcome Trust WT091663MA
6 · The paper itself

Abstract

CD161 is a C-type lectin-like receptor expressed on the majority of natural killer (NK) cells; however, the significance of CD161 expression on NK cells has not been comprehensively investigated. Recently, we found that CD161 expression identifies a transcriptional and innate functional phenotype that is shared across various T cell populations. Using mass cytometry and microarray experiments, we demonstrate that this functional phenotype extends to NK cells. CD161 marks NK cells that have retained the ability to respond to innate cytokines during their differentiation, and is lost upon cytomegalovirus-induced maturation in both healthy and human immunodeficiency virus (HIV)-infected patients. These pro-inflammatory NK cells are present in the inflamed lamina propria where they are enriched for integrin CD103 expression. Thus, CD161 expression identifies NK cells that may contribute to inflammatory disease pathogenesis and correlates with an innate responsiveness to cytokines in both T and NK cells.

Indexed as

Antigens, CDFemaleGene Expression RegulationHIV-1HIV InfectionsHumansImmunity, InnateIntegrin alpha ChainsKiller Cells, NaturalMaleNK Cell Lectin-Like Receptor Subfamily Balpha E integrinsAntigens, CDIntegrin alpha ChainsKLRB1 protein, humanNK Cell Lectin-Like Receptor Subfamily BCD161cytomegalovirushuman immunodeficiency virusinflammatory bowel diseasesnatural killer cellspro-inflammatory cytokines

Identifiers

PMID29686665
PMCPMC5900032
OpenAlexW2800082167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.